Elite Consulting develops actionable regional growth strategies and market entry plans for international companies with interests in China market. We provide consulting services in streamlining value chain for organizational effectiveness and international collaboration for Chinese companies. We also provide market planning and sales force placement and market plan implementation for both Chinese manufacturers and international firms.
Elite Consulting provide services in commercial due diligence, market opportunity and regulatory assessments, and market entry support for companies in need. Our clients range from VC/PE fund backed companies and SMEs in pharma / biopharma and medtech with strong interest in China market.
Elite’s extensive network and relationship with the domestic industry give us a unique niche in securing high-value investment opportunities in healthcare industry. These include search potential investment targets and negotiating terms and deals with target companies on behalf our clients. We serve both sell side and buy side clients.
Elite provide regulatory and medical marketing implementation services for venture backed companies and international SMEs. With comprehensive understanding of the regulatory processes in drug and device filing and relationship with relevant agencies and institutions, Elite Consulting offers a wide range of services, including NMPA registration, KOL mapping for clinical trial, KOL recruitment and engagement management, CFDA clinical trial protocol development, and clinical trial management.
For domestic and international pharmaceutical and medtech companies, Elite offers sales and marketing training services. Elite has performed training sessions for over 1,500 pharmaceutical and medical medtech companies. More than 100,000 professionals have graduated from our training programs. Our training team is composed of established and highly experienced veterans in healthcare industry and offers a unique blend of insights and techniques to improve your organizational performance.